Effect of adding HD-tDCS to regular treatment on social cognition in schizophrenia and its correlation with blood levels of oxytoci
- Conditions
- Health Condition 1: F202- Catatonic schizophreniaHealth Condition 2: F201- Disorganized schizophreniaHealth Condition 3: F208- Other schizophreniaHealth Condition 4: F200- Paranoid schizophreniaHealth Condition 5: F205- Residual schizophreniaHealth Condition 6: F209- Schizophrenia, unspecifiedHealth Condition 7: F203- Undifferentiated schizophrenia
- Registration Number
- CTRI/2023/08/056169
- Lead Sponsor
- Central Institute of Psychiatry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Diagnosis of Schizophrenia using Diagnostic Criteria for Research (DCR) of International Classification of Disease-11th edition (ICD-11, World Health Organization,1993)
2.Males aged between 18- 60 years
3.Illness duration of equal to or more than 2 years.
4.Patients giving written informed consent.
5.Right handed.
6.The Positive and Negative Syndrome Scale for Schizophrenia (PANSS), positive score less than 11.
7.Calgary Depression Scale for Schizophrenia (CDSS) score less than7.
1.Co-morbid neurological or any other medical or psychiatric disorder
2.History of substance abuse(except nicotine and caffeine)
3.History of epilepsy, significant head injury or any other neurosurgical procedures
4.Patients who have received electroconvulsive therapy or neuromodulation techniques in the past one month
5.Having any metallic implants in body
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Impact on social cognition after application of HD-tDCSTimepoint: Social cognition at baseline & 04 weeks after HDtDCS treatment
- Secondary Outcome Measures
Name Time Method Change in serum oxytocin from baseline to post treatmentTimepoint: Serum oxytocin levels at baseline & 04 weeks after HDtDCS treatment